3Dutcher JP, Wiemik PH, Markus S, et al. Intensive maintenance therapy improve survive in adult acute nonlymphocyiic leukemia:an eight-year follow-up[J]. Leukemia, 1988, 2(7): 413-419.
4Umezawa H, Takahashi Y, Kinoshita M, et at. Tetrahydropyranyl derivative of daunomycin and adriamycin [J]. Antibiot, 1979, 32(10): 1082-1084.
5Okuma K, Furuta I, Ota K. Acute cardiotixicity of anthracyclines analysis by using Holter[J]. Jpn Cancer Chemother Pharmacol, 1984, 11(2): 901-911.
6Umezawa H, Takahashi Y, Kinoshita M, et al.Tetrahydropyranyl derivative of daunomycin and adriamycin[J]. J Antibiot, 1979, 32(10):1082-1054.
7张之南.血液学诊断及疗效标准[M].北京:科学出版社,1998.171-194.
8Yamada K, Shirakawa S, Ohno R, et al. A phase Ⅱ study of (2'R)-4vO-tetrahydropyranyl adriamycin(THP) in patients with hematological malignancies [J]. Invest New Drug, 1987, 5:299-305.
9Ohno R, Kimura K, Amaki I, et al.Treatment of acute leukemia and malignant lymphoma with (2'R) - 4' - 0 - tetrahyodropyranyl adrimaycin [J]. Cancer Chemotherapy and Pharmacology, 1987, 20:230.
10Umegawa H,Takahashi Y, Kinoshita M, et al. Tetrahydropyranyl derivative of daunomycin and adriamycin. J Antibiot, 1979,32: 1082-1089.
